US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

IN8bio, Inc.

1.71

-0.0700-3.93%

Volume:11.12K

Turnover:19.47K

Market Cap:7.92M

PE:-0.18

High:1.79

Open:1.77

Low:1.71

Close:1.78

52wk High:12.53

52wk Low:1.53

Shares:4.63M

Float Shares:4.28M

Volume Ratio:1.54

T/O Rate:0.26%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-9.5432

EPS(LYR):-17.0525

ROE:-189.72%

ROA:-80.39%

PB:0.60

PE(LYR):-0.10

Loading ...

Overview Company News Filings

IN8bio Presents Promising Clinical Trial Results

IN8BIO Reports Promising Survival Data for DeltEx DRI Cells in Glioblastoma Trial

IN8BIO Showcases Advances in Gamma-Delta T Cell Therapies in New Corporate Presentation

BRIEF-In8bio Inc Files For Mixed Shelf Offering Of Upto $200 Million - SEC Filing

Analysts Offer Insights on Healthcare Companies: Skye Bioscience (SKYE) and IN8bio (INAB)

IN8Bio Reports Improved Financials Amid Ongoing Challenges

IN8bio Q3 EPS $(0.85) Beats $(1.25) Estimate

IN8bio Q3 net loss narrows to $3.9 mln, R&D expenses down

IN8BIO Expands Phase 1 INB-100 Gamma-Delta T Cell Therapy Trial to Ohio State University

IN8BIO Reports Q3 2025 Results and Advances Gamma-Delta T Cell Therapy Pipeline

IN8bio Inc expected to post a loss of $1.23 a share - Earnings Preview

IN8bio Expands Inb-100 Phase 1 Clinical Trial With Addition of the Ohio State University as New Site

THOMSON REUTERS

IN8bio Expands INB-100 Phase 1 Clinical Trial with Addition of The Ohio State University as New Site

IN8bio Inc - Inb-619 Shows Equivalent Efficacy to FDA-Approved Tce Compounds

THOMSON REUTERS

IN8bio Presents T cell Engager Data Demonstrating Deep B Cell Depletion for Autoimmune Indications

IN8bio price target adjusted to $4 from $60 at Mizuho

IN8bio Inc : Mizuho Adjusts Target Price to $4 From $60 to Reflect Reverse Stock Split

THOMSON REUTERS

Mizuho Securities Reaffirms Their Buy Rating on IN8bio (INAB)

IN8bio Inc reports results for the quarter ended June 30 - Earnings Summary

IN8bio Q2 EPS $(1.24) Beats $(1.70) Estimate

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/INAB/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"INAB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INAB\",,,,,undefined,":{"symbol":"INAB","market":"US","secType":"STK","nameCN":"IN8bio, Inc.","latestPrice":1.71,"timestamp":1765295284617,"preClose":1.78,"halted":0,"volume":11123,"delay":0,"floatShares":4277100,"shares":4634400,"eps":-9.543181,"marketStatus":"Trading","change":-0.07,"latestTime":"12-09 10:51:13 EST","open":1.77,"high":1.79,"low":1.71,"amount":19469.0473922,"amplitude":0.044944,"askPrice":1.77,"askSize":132,"bidPrice":1.7,"bidSize":195,"shortable":3,"etf":0,"ttmEps":-9.543181,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1765314000000},"marketStatusCode":2,"adr":0,"listingDate":1605157200000,"exchange":"NASDAQ","adjPreClose":1.78,"preHourTrading":{"tag":"盘前","latestPrice":1.8163,"preClose":1.78,"latestTime":"08:00 EST","volume":400,"amount":726.52,"timestamp":1765285202275},"postHourTrading":{"tag":"盘后","latestPrice":1.7898,"preClose":1.78,"latestTime":"19:19 EST","volume":1252,"amount":2222.1012,"timestamp":1765239549010},"volumeRatio":1.542119},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INAB\",,,,,undefined,":{"symbol":"INAB","floatShares":4277100,"roa":"-80.39%","roe":"-189.72%","lyrEps":-17.052505,"volumeRatio":1.542119,"shares":4634400,"dividePrice":0,"high":1.79,"amplitude":0.044944,"preClose":1.78,"low":1.71,"week52Low":1.5301,"pbRate":"0.60","week52High":12.531,"institutionHeld":0,"latestPrice":1.71,"committee":0.192661,"eps":-9.543181,"divideRate":0,"volume":11123,"delay":0,"ttmEps":-9.543181,"open":1.77,"prevYearClose":7.716,"prevWeekClose":1.77,"prevMonthClose":1.98,"prevQuarterClose":2.17,"fiveDayClose":1.78,"twentyDayClose":1.72,"sixtyDayClose":2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INAB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-06","symbol":"INAB","fiscalQuarterEnding":"2025/09","expectedEps":-1.2,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-0.85},{"market":"US","date":"2025-08-07","symbol":"INAB","fiscalQuarterEnding":"2025/06","expectedEps":-1.5,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-1.24},{"market":"US","date":"2025-06-06","symbol":"INAB","defaultRemindTime":1749216600000,"type":"split","dateTimestamp":1749182400000,"forFactor":30,"toFactor":1,"ratio":30},{"market":"US","date":"2025-05-07","symbol":"INAB","fiscalQuarterEnding":"2025/03","expectedEps":-0.06,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"post","actualEps":-0.07},{"market":"US","date":"2021-09-10","symbol":"INAB","fiscalQuarterEnding":"2021/06","expectedEps":-0.3,"name":null,"time":"","type":"earning","dateTimestamp":1631246400000,"reportTimeType":"","actualEps":1}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INAB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INAB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1739509200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/INAB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"INAB","date":"2025-12-08","current":-0.186521,"percent":0.920035,"low":-60.555129,"twenty":-5.196943,"median":-1.606109,"eighty":-0.544088,"high":-0.259966,"avg":-6.209546,"sd":13.887152,"marketCap":8202880},"quantilePoints":[{"date":"2020-12-11","current":-60.555129,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":310890032},{"date":"2020-12-18","current":-60.555129,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":310890032},{"date":"2020-12-24","current":-60.555129,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":310890032},{"date":"2020-12-31","current":-60.555129,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":310890032},{"date":"2021-01-08","current":-60.555129,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":310890032},{"date":"2021-01-15","current":-60.555129,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":310890032},{"date":"2021-01-22","current":-60.555129,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":310890032},{"date":"2021-01-29","current":-60.555129,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":310890032},{"date":"2021-02-05","current":-60.555129,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":310890032},{"date":"2021-02-12","current":-60.555129,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":310890032},{"date":"2021-02-19","current":-60.555129,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":310890032},{"date":"2021-02-26","current":-60.555129,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":310890032},{"date":"2021-03-05","current":-60.555129,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":310890032},{"date":"2021-03-11","current":-60.555129,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":310890032},{"date":"2021-07-30","current":-20.321327,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":187545530},{"date":"2021-08-06","current":-19.792973,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":182669346},{"date":"2021-08-13","current":-19.000441,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":175355070},{"date":"2021-08-20","current":-15.667743,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":144597603},{"date":"2021-08-27","current":-14.936176,"twenty":-60.555129,"median":-60.555129,"eighty":-22.35346,"marketCap":137845964},{"date":"2021-09-03","current":-16.907344,"twenty":-60.555129,"median":-60.555129,"eighty":-20.215656,"marketCap":156037880},{"date":"2021-09-10","current":-17.727589,"twenty":-60.555129,"median":-60.555129,"eighty":-20.040893,"marketCap":166727976},{"date":"2021-09-17","current":-13.958732,"twenty":-60.555129,"median":-60.555129,"eighty":-19.085791,"marketCap":131281871},{"date":"2021-09-24","current":-15.155194,"twenty":-60.555129,"median":-60.555129,"eighty":-18.138817,"marketCap":142534602},{"date":"2021-10-01","current":-14.736432,"twenty":-60.555129,"median":-60.555129,"eighty":-17.663778,"marketCap":138596146},{"date":"2021-10-08","current":-12.881915,"twenty":-60.555129,"median":-60.555129,"eighty":-16.140999,"marketCap":121154412},{"date":"2021-10-15","current":-11.984369,"twenty":-60.555129,"median":-60.555129,"eighty":-15.651486,"marketCap":112712988},{"date":"2021-10-22","current":-13.280736,"twenty":-60.555129,"median":-60.555129,"eighty":-14.97998,"marketCap":124905322},{"date":"2021-10-29","current":-15.135253,"twenty":-60.555129,"median":-60.555129,"eighty":-14.672621,"marketCap":142347057},{"date":"2021-11-05","current":-14.955784,"twenty":-60.555129,"median":-60.555129,"eighty":-14.748397,"marketCap":140659147},{"date":"2021-11-12","current":-14.224101,"twenty":-60.555129,"median":-60.555129,"eighty":-14.60881,"marketCap":158100881},{"date":"2021-11-19","current":-11.473771,"twenty":-60.555129,"median":-22.35346,"eighty":-14.426892,"marketCap":127530960},{"date":"2021-11-26","current":-11.389405,"twenty":-60.555129,"median":-22.35346,"eighty":-13.958732,"marketCap":126593232},{"date":"2021-12-03","current":-9.448987,"twenty":-60.555129,"median":-20.321327,"eighty":-13.818503,"marketCap":105025496},{"date":"2021-12-10","current":-11.170053,"twenty":-60.555129,"median":-20.199399,"eighty":-13.58292,"marketCap":124155140},{"date":"2021-12-17","current":-10.36014,"twenty":-60.555129,"median":-20.04699,"eighty":-13.380441,"marketCap":115152955},{"date":"2021-12-23","current":-10.377013,"twenty":-60.555129,"median":-19.843776,"eighty":-13.252819,"marketCap":115340500},{"date":"2021-12-31","current":-7.407331,"twenty":-60.555129,"median":-19.000441,"eighty":-12.570834,"marketCap":82332487},{"date":"2022-01-07","current":-7.230163,"twenty":-60.555129,"median":-18.461926,"eighty":-12.206067,"marketCap":80363259},{"date":"2022-01-14","current":-6.833643,"twenty":-60.555129,"median":-17.887117,"eighty":-11.984528,"marketCap":75955939},{"date":"2022-01-21","current":-5.419838,"twenty":-60.555129,"median":-17.727589,"eighty":-11.677476,"marketCap":60241499},{"date":"2022-01-28","current":-5.061958,"twenty":-60.555129,"median":-16.898705,"eighty":-11.301664,"marketCap":56263659},{"date":"2022-02-04","current":-5.483787,"twenty":-60.555129,"median":-16.175776,"eighty":-10.967575,"marketCap":60952297},{"date":"2022-02-11","current":-7.069867,"twenty":-60.555129,"median":-15.983021,"eighty":-10.387137,"marketCap":78581577},{"date":"2022-02-18","current":-6.81677,"twenty":-60.555129,"median":-15.647422,"eighty":-10.120541,"marketCap":75768394},{"date":"2022-02-25","current":-7.322965,"twenty":-60.555129,"median":-15.411038,"eighty":-9.418616,"marketCap":81394760},{"date":"2022-03-04","current":-7.13736,"twenty":-60.555129,"median":-15.198094,"eighty":-9.287005,"marketCap":79331759},{"date":"2022-03-11","current":-5.399421,"twenty":-60.555129,"median":-15.055489,"eighty":-7.731297,"marketCap":60014569},{"date":"2022-03-18","current":-3.748845,"twenty":-60.555129,"median":-14.955784,"eighty":-7.444452,"marketCap":54931819},{"date":"2022-03-25","current":-4.288062,"twenty":-60.555129,"median":-14.796256,"eighty":-7.302717,"marketCap":62832971},{"date":"2022-04-01","current":-4.416447,"twenty":-60.555129,"median":-14.626756,"eighty":-7.171106,"marketCap":64714198},{"date":"2022-04-08","current":-5.289466,"twenty":-60.555129,"median":-14.428142,"eighty":-7.076617,"marketCap":77506540},{"date":"2022-04-14","current":-4.4687,"twenty":-60.555129,"median":-14.426579,"eighty":-6.951755,"marketCap":65479857},{"date":"2022-04-22","current":-4.64754,"twenty":-60.555129,"median":-14.038496,"eighty":-6.889324,"marketCap":68100406},{"date":"2022-04-29","current":-3.081242,"twenty":-60.555129,"median":-13.958732,"eighty":-6.820145,"marketCap":45149440},{"date":"2022-05-06","current":-3.346101,"twenty":-60.555129,"median":-13.77786,"eighty":-6.48268,"marketCap":49030411},{"date":"2022-05-13","current":-2.840843,"twenty":-60.555129,"median":-13.659616,"eighty":-6.014858,"marketCap":52370949},{"date":"2022-05-20","current":-2.237931,"twenty":-60.555129,"median":-13.521562,"eighty":-5.632272,"marketCap":41256251},{"date":"2022-05-27","current":-2.411651,"twenty":-60.555129,"median":-13.380441,"eighty":-5.517534,"marketCap":44458791},{"date":"2022-06-03","current":-2.707998,"twenty":-60.555129,"median":-13.280736,"eighty":-5.419838,"marketCap":49921948},{"date":"2022-06-10","current":-2.452527,"twenty":-60.555129,"median":-13.051414,"eighty":-5.315055,"marketCap":45212330},{"date":"2022-06-17","current":-2.3299,"twenty":-60.555129,"median":-12.582799,"eighty":-5.161081,"marketCap":42951713},{"date":"2022-06-24","current":-2.483183,"twenty":-60.555129,"median":-12.363448,"eighty":-4.711057,"marketCap":45777484},{"date":"2022-07-01","current":-2.268587,"twenty":-60.555129,"median":-12.190881,"eighty":-4.552535,"marketCap":41821405},{"date":"2022-07-08","current":-2.499738,"twenty":-60.555129,"median":-12.131058,"eighty":-4.42415,"marketCap":46082667},{"date":"2022-07-15","current":-2.217493,"twenty":-60.555129,"median":-11.984369,"eighty":-4.339416,"marketCap":40879482},{"date":"2022-07-22","current":-2.457636,"twenty":-60.555129,"median":-11.64557,"eighty":-4.254681,"marketCap":45306522},{"date":"2022-07-29","current":-2.595591,"twenty":-60.555129,"median":-11.473771,"eighty":-4.172515,"marketCap":47849716},{"date":"2022-08-05","current":-2.452527,"twenty":-60.555129,"median":-11.170053,"eighty":-3.923449,"marketCap":45212330},{"date":"2022-08-12","current":-1.544548,"twenty":-60.555129,"median":-11.035068,"eighty":-3.402872,"marketCap":34851171},{"date":"2022-08-19","current":-1.998049,"twenty":-60.555129,"median":-10.75666,"eighty":-3.158273,"marketCap":45083968},{"date":"2022-08-26","current":-2.128356,"twenty":-60.555129,"median":-10.377013,"eighty":-2.846974,"marketCap":48024227},{"date":"2022-09-02","current":-2.617009,"twenty":-60.555129,"median":-10.284211,"eighty":-2.79112,"marketCap":59050198},{"date":"2022-09-09","current":-2.682163,"twenty":-60.555129,"median":-9.879254,"eighty":-2.656101,"marketCap":60520327},{"date":"2022-09-16","current":-2.725599,"twenty":-60.555129,"median":-9.398368,"eighty":-2.67239,"marketCap":61500414},{"date":"2022-09-23","current":-2.160933,"twenty":-60.555129,"median":-9.330876,"eighty":-2.636466,"marketCap":48759292},{"date":"2022-09-30","current":-2.19351,"twenty":-60.555129,"median":-7.947273,"eighty":-2.595591,"marketCap":49494357},{"date":"2022-10-07","current":-2.258664,"twenty":-60.555129,"median":-7.736358,"eighty":-2.505541,"marketCap":50964486},{"date":"2022-10-14","current":-2.182651,"twenty":-60.555129,"median":-7.474824,"eighty":-2.483183,"marketCap":49249335},{"date":"2022-10-21","current":-1.607126,"twenty":-60.555129,"median":-7.415767,"eighty":-2.467985,"marketCap":36263192},{"date":"2022-10-28","current":-2.008908,"twenty":-60.555129,"median":-7.322965,"eighty":-2.452568,"marketCap":45328990},{"date":"2022-11-04","current":-1.954613,"twenty":-60.555129,"median":-7.225945,"eighty":-2.452527,"marketCap":44103882},{"date":"2022-11-11","current":-1.576798,"twenty":-45.274461,"median":-7.13736,"eighty":-2.40552,"marketCap":41898688},{"date":"2022-11-18","current":-1.318609,"twenty":-22.35346,"median":-7.086741,"eighty":-2.353137,"marketCap":35038084},{"date":"2022-11-25","current":-1.493809,"twenty":-22.35346,"median":-7.044557,"eighty":-2.336787,"marketCap":39693494},{"date":"2022-12-02","current":-1.954861,"twenty":-22.35346,"median":-6.951755,"eighty":-2.319682,"marketCap":51944572},{"date":"2022-12-09","current":-2.176166,"twenty":-21.947033,"median":-6.91379,"eighty":-2.291069,"marketCap":57825090},{"date":"2022-12-16","current":-1.576798,"twenty":-20.321327,"median":-6.867389,"eighty":-2.277598,"marketCap":41898688},{"date":"2022-12-23","current":-1.632125,"twenty":-20.30507,"median":-6.825207,"eighty":-2.25851,"marketCap":43368817},{"date":"2022-12-30","current":-2.130061,"twenty":-20.240042,"median":-6.79146,"eighty":-2.249935,"marketCap":56599982},{"date":"2023-01-06","current":-2.609555,"twenty":-20.207528,"median":-6.500397,"eighty":-2.249578,"marketCap":69341104},{"date":"2023-01-13","current":-2.130061,"twenty":-20.101857,"median":-6.293701,"eighty":-2.248149,"marketCap":56599982},{"date":"2023-01-20","current":-2.139282,"twenty":-20.065278,"median":-6.008422,"eighty":-2.222649,"marketCap":56845004},{"date":"2023-01-27","current":-2.102398,"twenty":-20.044957,"median":-5.763894,"eighty":-2.196076,"marketCap":55864917},{"date":"2023-02-03","current":-2.231493,"twenty":-19.951479,"median":-5.568153,"eighty":-2.194169,"marketCap":59295219},{"date":"2023-02-10","current":-1.779661,"twenty":-19.833615,"median":-5.517534,"eighty":-2.176617,"marketCap":47289163},{"date":"2023-02-17","current":-1.800593,"twenty":-19.573503,"median":-5.483787,"eighty":-2.16454,"marketCap":47845361},{"date":"2023-02-24","current":-1.346272,"twenty":-19.25649,"median":-5.405012,"eighty":-2.156798,"marketCap":35773149},{"date":"2023-03-03","current":-1.456925,"twenty":-18.976055,"median":-5.348802,"eighty":-2.139282,"marketCap":38713408},{"date":"2023-03-10","current":-1.171073,"twenty":-18.760649,"median":-5.247563,"eighty":-2.137131,"marketCap":31117739},{"date":"2023-03-17","current":-1.078862,"twenty":-18.468022,"median":-5.111519,"eighty":-2.129038,"marketCap":28667523},{"date":"2023-03-24","current":-1.134188,"twenty":-18.28513,"median":-4.724571,"eighty":-2.11729,"marketCap":30137653},{"date":"2023-03-31","current":-1.116819,"twenty":-17.994243,"median":-4.628283,"eighty":-2.093853,"marketCap":31852804},{"date":"2023-04-06","current":-1.013728,"twenty":-17.857797,"median":-4.525575,"eighty":-2.054716,"marketCap":28912545},{"date":"2023-04-14","current":-1.108228,"twenty":-17.737933,"median":-4.429286,"eighty":-2.044514,"marketCap":31607782},{"date":"2023-04-21","current":-0.9793,"twenty":-17.711636,"median":-4.39077,"eighty":-2.024631,"marketCap":27930624},{"date":"2023-04-28","current":-1.600107,"twenty":-17.499729,"median":-4.3009,"eighty":-2.010187,"marketCap":45636646},{"date":"2023-05-05","current":-2.002319,"twenty":-16.903888,"median":-4.281643,"eighty":-2.008908,"marketCap":57108152},{"date":"2023-05-12","current":-1.906138,"twenty":-16.800043,"median":-4.223869,"eighty":-2.008908,"marketCap":54364966},{"date":"2023-05-19","current":-3.134129,"twenty":-16.387118,"median":-4.172515,"eighty":-2.008908,"marketCap":93713596},{"date":"2023-05-26","current":-2.576951,"twenty":-16.167082,"median":-4.031292,"eighty":-2.009164,"marketCap":77053401},{"date":"2023-06-02","current":-3.044583,"twenty":-16.132305,"median":-3.87723,"eighty":-2.010187,"marketCap":91036064},{"date":"2023-06-09","current":-2.397858,"twenty":-16.013206,"median":-3.466397,"eighty":-2.010187,"marketCap":71698338},{"date":"2023-06-16","current":-2.109319,"twenty":-15.952836,"median":-3.338012,"eighty":-2.010187,"marketCap":63070737},{"date":"2023-06-23","current":-1.910326,"twenty":-15.724762,"median":-3.218941,"eighty":-2.008908,"marketCap":57120668},{"date":"2023-06-30","current":-1.611838,"twenty":-15.65555,"median":-3.138239,"eighty":-2.001778,"marketCap":48195563},{"date":"2023-07-07","current":-1.661586,"twenty":-15.570177,"median":-3.134129,"eighty":-1.998049,"marketCap":49683081},{"date":"2023-07-14","current":-1.691435,"twenty":-15.437001,"median":-3.034633,"eighty":-1.966279,"marketCap":50575591},{"date":"2023-07-21","current":-1.591939,"twenty":-15.343021,"median":-2.997073,"eighty":-1.948098,"marketCap":47600556},{"date":"2023-07-28","current":-1.238727,"twenty":-15.240995,"median":-2.910292,"eighty":-1.927198,"marketCap":37039183},{"date":"2023-08-04","current":-1.263601,"twenty":-15.206675,"median":-2.86549,"eighty":-1.903019,"marketCap":37782941},{"date":"2023-08-11","current":-1.144206,"twenty":-15.147218,"median":-2.826657,"eighty":-1.879294,"marketCap":34212900},{"date":"2023-08-18","current":-1.183602,"twenty":-15.103347,"median":-2.765993,"eighty":-1.844935,"marketCap":36025305},{"date":"2023-08-25","current":-1.059013,"twenty":-15.015607,"median":-2.720922,"eighty":-1.788034,"marketCap":32233167},{"date":"2023-09-01","current":-1.09016,"twenty":-14.955784,"median":-2.706296,"eighty":-1.751998,"marketCap":33181202},{"date":"2023-09-08","current":-1.005128,"twenty":-14.955784,"median":-2.665875,"eighty":-1.734645,"marketCap":30593068},{"date":"2023-09-15","current":-0.975953,"twenty":-14.951862,"median":-2.637688,"eighty":-1.702114,"marketCap":29705076},{"date":"2023-09-22","current":-1.204367,"twenty":-14.908192,"median":-2.636466,"eighty":-1.688248,"marketCap":36657328},{"date":"2023-09-29","current":-1.152455,"twenty":-14.784291,"median":-2.613282,"eighty":-1.672875,"marketCap":35077270},{"date":"2023-10-06","current":-1.017587,"twenty":-14.720479,"median":-2.595591,"eighty":-1.660148,"marketCap":30972282},{"date":"2023-10-13","current":-0.986335,"twenty":-14.644703,"median":-2.581926,"eighty":-1.631815,"marketCap":30021087},{"date":"2023-10-20","current":-0.996718,"twenty":-14.592857,"median":-2.545008,"eighty":-1.604995,"marketCap":30337099},{"date":"2023-10-27","current":-1.038248,"twenty":-14.58488,"median":-2.535787,"eighty":-1.598161,"marketCap":31601145},{"date":"2023-11-03","current":-1.038248,"twenty":-14.487647,"median":-2.512992,"eighty":-1.579913,"marketCap":31601145},{"date":"2023-11-10","current":-1.04863,"twenty":-14.428142,"median":-2.508124,"eighty":-1.53388,"marketCap":31917156},{"date":"2023-11-17","current":-0.975284,"twenty":-14.427204,"median":-2.499738,"eighty":-1.499342,"marketCap":29460407},{"date":"2023-11-24","current":-0.773116,"twenty":-14.345588,"median":-2.483183,"eighty":-1.472685,"marketCap":23353524},{"date":"2023-12-01","current":-0.879023,"twenty":-14.181765,"median":-2.475843,"eighty":-1.42357,"marketCap":26552637},{"date":"2023-12-08","current":-1.045507,"twenty":-14.054449,"median":-2.460191,"eighty":-1.396066,"marketCap":31581643},{"date":"2023-12-15","current":-2.478208,"twenty":-13.958732,"median":-2.457636,"eighty":-1.392378,"marketCap":74859244},{"date":"2023-12-22","current":-1.846609,"twenty":-13.958732,"median":-2.452578,"eighty":-1.396066,"marketCap":55780526},{"date":"2023-12-29","current":-2.032702,"twenty":-13.958732,"median":-2.452527,"eighty":-1.401599,"marketCap":61401819},{"date":"2024-01-05","current":-1.989757,"twenty":-13.925599,"median":-2.452527,"eighty":-1.402377,"marketCap":60104598},{"date":"2024-01-12","current":-2.204479,"twenty":-13.852506,"median":-2.432089,"eighty":-1.40765,"marketCap":66590705},{"date":"2024-01-19","current":-2.063553,"twenty":-13.785989,"median":-2.419201,"eighty":-1.41082,"marketCap":62333748},{"date":"2024-01-26","current":-1.86293,"twenty":-13.736241,"median":-2.404062,"eighty":-1.42357,"marketCap":56273522},{"date":"2024-02-02","current":-1.719628,"twenty":-13.704713,"median":-2.380995,"eighty":-1.448386,"marketCap":51944790},{"date":"2024-02-09","current":-1.748288,"twenty":-13.628938,"median":-2.367158,"eighty":-1.456925,"marketCap":52810536},{"date":"2024-02-16","current":-1.576325,"twenty":-13.58292,"median":-2.350965,"eighty":-1.460613,"marketCap":47616057},{"date":"2024-02-23","current":-1.447353,"twenty":-13.558377,"median":-2.345229,"eighty":-1.458769,"marketCap":43720198},{"date":"2024-03-01","current":-1.590655,"twenty":-13.444252,"median":-2.3299,"eighty":-1.456925,"marketCap":48048930},{"date":"2024-03-08","current":-1.748288,"twenty":-13.380441,"median":-2.319682,"eighty":-1.458769,"marketCap":52810536},{"date":"2024-03-15","current":-1.662307,"twenty":-13.376453,"median":-2.304353,"eighty":-1.46812,"marketCap":50213297},{"date":"2024-03-22","current":-1.803218,"twenty":-13.344547,"median":-2.289025,"eighty":-1.47731,"marketCap":54109156},{"date":"2024-03-28","current":-1.745515,"twenty":-13.280736,"median":-2.278806,"eighty":-1.482493,"marketCap":52377663},{"date":"2024-04-05","current":-1.615683,"twenty":-13.260795,"median":-2.273092,"eighty":-1.493809,"marketCap":48481804},{"date":"2024-04-12","current":-1.65896,"twenty":-13.220913,"median":-2.258664,"eighty":-1.493809,"marketCap":49780423},{"date":"2024-04-19","current":-1.514703,"twenty":-12.881915,"median":-2.256631,"eighty":-1.482493,"marketCap":45451691},{"date":"2024-04-26","current":-1.500277,"twenty":-12.662564,"median":-2.248149,"eighty":-1.482493,"marketCap":45018818},{"date":"2024-05-03","current":-1.496325,"twenty":-12.582799,"median":-2.24304,"eighty":-1.482493,"marketCap":44900232},{"date":"2024-05-10","current":-1.432162,"twenty":-12.522976,"median":-2.231493,"eighty":-1.471426,"marketCap":44460034},{"date":"2024-05-17","current":-1.446342,"twenty":-12.363448,"median":-2.22179,"eighty":-1.466146,"marketCap":44900232},{"date":"2024-05-24","current":-1.47456,"twenty":-12.249186,"median":-2.21305,"eighty":-1.460522,"marketCap":45776227},{"date":"2024-05-31","current":-1.463976,"twenty":-12.22279,"median":-2.204479,"eighty":-1.456925,"marketCap":45447667},{"date":"2024-06-07","current":-1.606109,"twenty":-12.175695,"median":-2.195832,"eighty":-1.459803,"marketCap":49860062},{"date":"2024-06-14","current":-2.387844,"twenty":-12.164651,"median":-2.194059,"eighty":-1.462594,"marketCap":74128234},{"date":"2024-06-21","current":-1.307913,"twenty":-12.137654,"median":-2.185365,"eighty":-1.456925,"marketCap":40602857},{"date":"2024-06-28","current":-1.278207,"twenty":-12.111271,"median":-2.180423,"eighty":-1.456032,"marketCap":39680667},{"date":"2024-07-05","current":-1.134937,"twenty":-12.029972,"median":-2.177406,"eighty":-1.446342,"marketCap":35232973},{"date":"2024-07-12","current":-1.194064,"twenty":-11.984449,"median":-2.176166,"eighty":-1.442646,"marketCap":37068529},{"date":"2024-07-15","current":-1.247649,"twenty":-11.984409,"median":-2.173979,"eighty":-1.442545,"marketCap":38732002},{"date":"2024-08-02","current":-1.208135,"twenty":-11.984369,"median":-2.171792,"eighty":-1.44243,"marketCap":37505356},{"date":"2024-08-09","current":-0.972336,"twenty":-11.964627,"median":-2.163939,"eighty":-1.432162,"marketCap":30185193},{"date":"2024-08-16","current":-0.882654,"twenty":-11.805099,"median":-2.157724,"eighty":-1.410954,"marketCap":28207850},{"date":"2024-08-23","current":-0.761433,"twenty":-11.486042,"median":-2.153127,"eighty":-1.401599,"marketCap":24333891},{"date":"2024-08-30","current":-0.760116,"twenty":-11.473771,"median":-2.145961,"eighty":-1.383157,"marketCap":24291783},{"date":"2024-09-06","current":-0.49469,"twenty":-11.473771,"median":-2.139282,"eighty":-1.363657,"marketCap":15809309},{"date":"2024-09-13","current":-0.440961,"twenty":-11.406278,"median":-2.139215,"eighty":-1.340739,"marketCap":14092228},{"date":"2024-09-20","current":-0.470095,"twenty":-11.213923,"median":-2.135742,"eighty":-1.289457,"marketCap":15023289},{"date":"2024-09-27","current":-0.417244,"twenty":-11.170053,"median":-2.130061,"eighty":-1.276954,"marketCap":13334280},{"date":"2024-10-04","current":-0.3865,"twenty":-11.143056,"median":-2.126474,"eighty":-1.252451,"marketCap":12351754},{"date":"2024-10-11","current":-0.336577,"twenty":-11.055316,"median":-2.117497,"eighty":-1.235515,"marketCap":10756319},{"date":"2024-10-18","current":-0.33687,"twenty":-10.900082,"median":-2.109319,"eighty":-1.21758,"marketCap":10765676},{"date":"2024-10-25","current":-0.468631,"twenty":-10.812342,"median":-2.095323,"eighty":-1.203755,"marketCap":14976502},{"date":"2024-10-31","current":-0.39543,"twenty":-10.748223,"median":-2.092695,"eighty":-1.194032,"marketCap":12637154},{"date":"2024-11-08","current":-0.484003,"twenty":-10.522122,"median":-2.089364,"eighty":-1.182279,"marketCap":15467765},{"date":"2024-11-15","current":-0.493189,"twenty":-10.383762,"median":-2.069928,"eighty":-1.172361,"marketCap":15720414},{"date":"2024-11-22","current":-0.727675,"twenty":-10.366889,"median":-2.063526,"eighty":-1.163203,"marketCap":23194640},{"date":"2024-11-29","current":-0.692883,"twenty":-10.333143,"median":-2.052343,"eighty":-1.153748,"marketCap":22085647},{"date":"2024-12-06","current":-0.682195,"twenty":-10.285898,"median":-2.047072,"eighty":-1.146883,"marketCap":21744975},{"date":"2024-12-13","current":-0.66082,"twenty":-10.120541,"median":-2.043874,"eighty":-1.13907,"marketCap":21063633},{"date":"2024-12-20","current":-0.546666,"twenty":-9.880941,"median":-2.034998,"eighty":-1.134188,"marketCap":17424974},{"date":"2024-12-27","current":-0.578502,"twenty":-9.786451,"median":-2.03022,"eighty":-1.134038,"marketCap":18439739},{"date":"2025-01-03","current":-0.63717,"twenty":-9.448987,"median":-2.021551,"eighty":-1.122855,"marketCap":20309807},{"date":"2025-01-10","current":-0.710847,"twenty":-9.408492,"median":-2.010187,"eighty":-1.116819,"marketCap":22658264},{"date":"2025-01-17","current":-0.674464,"twenty":-9.371371,"median":-2.008908,"eighty":-1.107887,"marketCap":21498532},{"date":"2025-01-24","current":-0.652179,"twenty":-9.364622,"median":-2.004072,"eighty":-1.101073,"marketCap":20788196},{"date":"2025-01-31","current":-0.563721,"twenty":-9.324126,"median":-2.001642,"eighty":-1.097961,"marketCap":17968598},{"date":"2025-02-07","current":-0.629894,"twenty":-9.287005,"median":-1.998049,"eighty":-1.084711,"marketCap":20077861},{"date":"2025-02-14","current":-0.734724,"twenty":-8.480466,"median":-1.989757,"eighty":-1.079412,"marketCap":23419339},{"date":"2025-02-21","current":-0.65036,"twenty":-7.873031,"median":-1.984857,"eighty":-1.069395,"marketCap":20730210},{"date":"2025-02-28","current":-0.576228,"twenty":-7.761668,"median":-1.963783,"eighty":-1.052376,"marketCap":18367256},{"date":"2025-03-07","current":-0.58828,"twenty":-7.74142,"median":-1.954613,"eighty":-1.046541,"marketCap":18751417},{"date":"2025-03-14","current":-0.514603,"twenty":-7.684052,"median":-1.94723,"eighty":-1.038248,"marketCap":16402960},{"date":"2025-03-21","current":-0.621782,"twenty":-7.576063,"median":-1.937378,"eighty":-1.029162,"marketCap":18925165},{"date":"2025-03-28","current":-0.555572,"twenty":-7.474824,"median":-1.932498,"eighty":-1.018376,"marketCap":16909948},{"date":"2025-04-04","current":-0.430361,"twenty":-7.454576,"median":-1.923725,"eighty":-1.015188,"marketCap":13098912},{"date":"2025-04-11","current":-0.392718,"twenty":-7.417455,"median":-1.910326,"eighty":-1.00529,"marketCap":11953164},{"date":"2025-04-17","current":-0.42075,"twenty":-7.400582,"median":-1.906138,"eighty":-0.992946,"marketCap":12806381},{"date":"2025-04-25","current":-0.493901,"twenty":-7.363461,"median":-1.902764,"eighty":-0.983856,"marketCap":15032871},{"date":"2025-05-02","current":-0.453588,"twenty":-7.316216,"median":-1.899535,"eighty":-0.976534,"marketCap":13805863},{"date":"2025-05-09","current":-0.497478,"twenty":-7.277408,"median":-1.883407,"eighty":-0.972926,"marketCap":13643346},{"date":"2025-05-16","current":-0.438552,"twenty":-7.228476,"median":-1.871872,"eighty":-0.963991,"marketCap":12027282},{"date":"2025-05-23","current":-0.439545,"twenty":-7.221726,"median":-1.86293,"eighty":-0.937651,"marketCap":12054514},{"date":"2025-05-30","current":-0.507727,"twenty":-7.221726,"median":-1.86244,"eighty":-0.918094,"marketCap":13924416},{"date":"2025-06-06","current":-0.452491,"twenty":-7.13736,"median":-1.85343,"eighty":-0.881988,"marketCap":12409571},{"date":"2025-06-13","current":-0.298898,"twenty":-7.120487,"median":-1.846259,"eighty":-0.836826,"marketCap":8197267},{"date":"2025-06-20","current":-0.267501,"twenty":-7.09349,"median":-1.844209,"eighty":-0.789983,"marketCap":7336209},{"date":"2025-06-27","current":-0.271268,"twenty":-7.086741,"median":-1.819939,"eighty":-0.773116,"marketCap":7439536},{"date":"2025-07-03","current":-0.27378,"twenty":-7.076617,"median":-1.803218,"eighty":-0.769837,"marketCap":7508421},{"date":"2025-07-11","current":-0.287595,"twenty":-7.039496,"median":-1.795936,"eighty":-0.758828,"marketCap":7887286},{"date":"2025-07-18","current":-0.276292,"twenty":-6.978752,"median":-1.788792,"eighty":-0.734997,"marketCap":7577306},{"date":"2025-07-25","current":-0.302665,"twenty":-6.951755,"median":-1.776194,"eighty":-0.730523,"marketCap":8300594},{"date":"2025-08-01","current":-0.267501,"twenty":-6.941631,"median":-1.775035,"eighty":-0.721671,"marketCap":7336209},{"date":"2025-08-08","current":-0.270013,"twenty":-6.924758,"median":-1.766314,"eighty":-0.708482,"marketCap":7405094},{"date":"2025-08-15","current":-0.456062,"twenty":-6.912947,"median":-1.751998,"eighty":-0.69467,"marketCap":10895320},{"date":"2025-08-22","current":-0.425658,"twenty":-6.894386,"median":-1.74829,"eighty":-0.690108,"marketCap":10168966},{"date":"2025-08-29","current":-0.429458,"twenty":-6.874138,"median":-1.748288,"eighty":-0.678245,"marketCap":10259760},{"date":"2025-09-05","current":-0.414256,"twenty":-6.853891,"median":-1.745515,"eighty":-0.665277,"marketCap":9896583},{"date":"2025-09-12","current":-0.397154,"twenty":-6.833643,"median":-1.732763,"eighty":-0.657272,"marketCap":9488008},{"date":"2025-09-19","current":-0.391453,"twenty":-6.826894,"median":-1.731089,"eighty":-0.65036,"marketCap":9351817},{"date":"2025-09-26","current":-0.397154,"twenty":-6.81677,"median":-1.722809,"eighty":-0.632804,"marketCap":9488008},{"date":"2025-10-03","current":-0.435159,"twenty":-6.796522,"median":-1.719628,"eighty":-0.622116,"marketCap":10395951},{"date":"2025-10-10","current":-0.44276,"twenty":-6.67166,"median":-1.703635,"eighty":-0.615477,"marketCap":10577540},{"date":"2025-10-17","current":-0.400954,"twenty":-6.506303,"median":-1.696672,"eighty":-0.61102,"marketCap":9578802},{"date":"2025-10-24","current":-0.399054,"twenty":-6.4135,"median":-1.691412,"eighty":-0.608649,"marketCap":9533405},{"date":"2025-10-31","current":-0.378151,"twenty":-6.313949,"median":-1.683139,"eighty":-0.604743,"marketCap":9034036},{"date":"2025-11-07","current":-0.315443,"twenty":-6.192462,"median":-1.674883,"eighty":-0.589735,"marketCap":7535930},{"date":"2025-11-14","current":-0.367916,"twenty":-5.748368,"median":-1.661586,"eighty":-0.581385,"marketCap":7600409},{"date":"2025-11-21","current":-0.356699,"twenty":-5.517534,"median":-1.651636,"eighty":-0.574045,"marketCap":7368689},{"date":"2025-11-28","current":-0.444191,"twenty":-5.410942,"median":-1.632125,"eighty":-0.562811,"marketCap":9176104},{"date":"2025-12-05","current":-0.408297,"twenty":-5.264324,"median":-1.607126,"eighty":-0.54994,"marketCap":8434600},{"date":"2025-12-08","current":-0.39708,"twenty":-5.196943,"median":-1.606109,"eighty":-0.544088,"marketCap":8202880}],"updateTime":1765272999922},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INAB\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2586149188","title":"IN8bio Presents Promising Clinical Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2586149188","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586149188?lang=en_us&edition=fundamental","pubTime":"2025-11-25 01:04","pubTimestamp":1764003888,"startTime":"0","endTime":"0","summary":"IN8bio ( ($INAB) ) has issued an announcement. IN8bio, Inc. presented data from its Phase 1 and Phase 2 clinical trials of INB-200 and INB-400 at t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/in8bio-presents-promising-clinical-trial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/in8bio-presents-promising-clinical-trial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","INAB"],"gpt_icon":0},{"id":"2586496697","title":"IN8BIO Reports Promising Survival Data for DeltEx DRI Cells in Glioblastoma Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2586496697","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586496697?lang=en_us&edition=fundamental","pubTime":"2025-11-25 00:17","pubTimestamp":1764001031,"startTime":"0","endTime":"0","summary":"IN8BIO Inc. has announced new clinical data from its investigator-sponsored Phase 1 trial of INB-200 and Company-sponsored Phase 2 trial of INB-400 for the treatment of newly diagnosed glioblastoma. The results were presented in poster and oral sessions at the 2025 Society for Neuro-Oncology  Annual Meeting on November 21 and 22, 2025. Across both trials, 17 patients were treated with the Company's DeltEx DRI gamma-delta T cells, with 14 patients receiving repeated doses. These patients achieved a median progression-free survival of 13.0 months, compared to 6.6 months for 10 patients who received only the standard-of-care Stupp protocol. Median overall survival for patients treated with repeated DeltEx DRI doses has not yet been reached and was reported at 16.4+ months as of October 31, 2025, while the standard-of-care group had a median overall survival of 11.0 months.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nNDL2dt6fH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","INAB"],"gpt_icon":0},{"id":"2585462068","title":"IN8BIO Showcases Advances in Gamma-Delta T Cell Therapies in New Corporate Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2585462068","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585462068?lang=en_us&edition=fundamental","pubTime":"2025-11-24 21:19","pubTimestamp":1763990363,"startTime":"0","endTime":"0","summary":"IN8BIO Inc. has released a corporate presentation highlighting recent developments across its pipeline of gamma-delta T cell therapies. The company provided updates on its DeltEx platform, with clinical milestones anticipated for programs in acute myeloid leukemia  and glioblastoma . For AML, IN8BIO plans to complete enrollment and dosing for additional patients in an expansion cohort, with ongoing clinical updates expected in 2026. In GBM, the company aims to report long-term overall survival data and Phase 2 trial results at upcoming scientific meetings. Efforts in autoimmune indications remain on hold, with potential advancement to IND-enabling studies in 2026. Additional details regarding program prioritization are available in the company's recent SEC filings. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely informat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nNDL1wB41y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","INAB","BK4139"],"gpt_icon":0},{"id":"2581121832","title":"BRIEF-In8bio Inc Files For Mixed Shelf Offering Of Upto $200 Million - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2581121832","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581121832?lang=en_us&edition=fundamental","pubTime":"2025-11-08 06:32","pubTimestamp":1762554728,"startTime":"0","endTime":"0","summary":"BRIEF-In8bio Inc Files For Mixed Shelf Offering Of Upto $200 Million - SEC FilingIN8bio Inc INAB.O:IN8BIO INC FILES FOR MIXED SHELF OFFERING OF UPTO $200 MILLION - SEC FILINGSource text: [ID:n0001193125-25-272565]Further company coverage: INAB.O","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nFWN3WJ2HD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","INAB"],"gpt_icon":0},{"id":"2581832638","title":"Analysts Offer Insights on Healthcare Companies: Skye Bioscience (SKYE) and IN8bio (INAB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2581832638","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581832638?lang=en_us&edition=fundamental","pubTime":"2025-11-08 06:10","pubTimestamp":1762553411,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Skye Bioscience (SKYE – Research Report) and IN8bio ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-skye-bioscience-skye-and-in8bio-inab-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-skye-bioscience-skye-and-in8bio-inab-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4581","LABU","SKYE","LU0029874061.USD","BK4588","BK4137","BK4139","XBI","HCSG","INAB","BK4585","XLV","BK4539"],"gpt_icon":0},{"id":"2581807804","title":"IN8Bio Reports Improved Financials Amid Ongoing Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2581807804","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581807804?lang=en_us&edition=fundamental","pubTime":"2025-11-07 14:01","pubTimestamp":1762495285,"startTime":"0","endTime":"0","summary":"In8bio, Inc. ( ($INAB) ) has released its Q3 earnings. Here is a breakdown of the information In8bio, Inc. presented to its investors. IN8Bio, Inc....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/in8bio-reports-improved-financials-amid-ongoing-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/in8bio-reports-improved-financials-amid-ongoing-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INAB","BK4539","BK4139"],"gpt_icon":0},{"id":"2581046196","title":"IN8bio Q3 EPS $(0.85) Beats $(1.25) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2581046196","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581046196?lang=en_us&edition=fundamental","pubTime":"2025-11-07 06:06","pubTimestamp":1762466800,"startTime":"0","endTime":"0","summary":"IN8bio Q3 EPS $(0.85) Beats $(1.25) Estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48706577/in8bio-q3-eps-0-85-beats-1-25-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"IN8bio Q3 EPS $(0.85) Beats $(1.25) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INAB"],"gpt_icon":0},{"id":"2581438150","title":"IN8bio Q3 net loss narrows to $3.9 mln, R&D expenses down","url":"https://stock-news.laohu8.com/highlight/detail?id=2581438150","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581438150?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:25","pubTimestamp":1762464327,"startTime":"0","endTime":"0","summary":"IN8bio Q3 net loss narrows to $3.9 mln, R&D expenses downOverviewIN8bio Q3 net loss narrows to $3.9 mln from $7.1 mln last yearR&D expenses for Q3 decreased due to strategic pause in INB-400 programCo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nL1N3WI1I0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INAB","BK4139","BK4539"],"gpt_icon":0},{"id":"2581201001","title":"IN8BIO Expands Phase 1 INB-100 Gamma-Delta T Cell Therapy Trial to Ohio State University","url":"https://stock-news.laohu8.com/highlight/detail?id=2581201001","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581201001?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:14","pubTimestamp":1762463676,"startTime":"0","endTime":"0","summary":"IN8bio Inc. has announced the expansion of its Phase 1 INB-100 clinical trial to The James Comprehensive Cancer Center at The Ohio State University, aiming to accelerate patient enrollment for this study of donor-derived, allogeneic gamma-delta (γδ) T cell therapy in patients with leukemias undergoing haploidentical stem cell transplantation. Additionally, the company presented new preclinical data on INB-619, a CD19-targeting γδ T cell engager, at the 2025 American College of Rheumatology  Convergence Meeting. The preclinical results demonstrated that INB-619 achieved complete elimination of B cells in systemic lupus erythematosus  donor models, with efficacy comparable to currently FDA-approved CD19 and CD20 engagers. Updated clinical data for INB-200/400 in newly diagnosed glioblastoma are planned to be presented at the 2025 Society for Neuro-Oncology  Annual Meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDL8bK3hQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INAB","BK4539","BK4139"],"gpt_icon":0},{"id":"2581121720","title":"IN8BIO Reports Q3 2025 Results and Advances Gamma-Delta T Cell Therapy Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2581121720","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581121720?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:00","pubTimestamp":1762462856,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IN8BIO Inc. published the original content used to generate this news brief via GlobeNewswire  on November 06, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDL4VG0JK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","BK4139","INAB","BK4112","BK4539","IE00BKPKM429.USD","IE00B64PRP62.GBP","BK4585","LU2210149790.SGD","BK4588","LU2210150020.SGD","LU2095319765.USD","LU0314104364.USD","NDAQ","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2580419285","title":"IN8bio Inc  expected to post a loss of $1.23 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2580419285","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580419285?lang=en_us&edition=fundamental","pubTime":"2025-11-01 05:02","pubTimestamp":1761944542,"startTime":"0","endTime":"0","summary":"IN8bio Inc  expected to post a loss of $1.23 a share - Earnings Preview IN8bio Inc INAB.OQ INAB.O is expected to  show no change in quarterly revenue when it reports  results on November 3 (estimated)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251031:nL8N3WC2EB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INAB","BK4139","BK4539"],"gpt_icon":0},{"id":"2579086429","title":"IN8bio Expands Inb-100 Phase 1 Clinical Trial With Addition of the Ohio State University as New Site","url":"https://stock-news.laohu8.com/highlight/detail?id=2579086429","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579086429?lang=en_us&edition=fundamental","pubTime":"2025-10-29 20:00","pubTimestamp":1761739204,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nTUABG740Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INAB","BK4539","BK4139"],"gpt_icon":0},{"id":"2579033789","title":"IN8bio Expands INB-100 Phase 1 Clinical Trial with Addition of The Ohio State University as New Site","url":"https://stock-news.laohu8.com/highlight/detail?id=2579033789","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579033789?lang=en_us&edition=fundamental","pubTime":"2025-10-29 20:00","pubTimestamp":1761739200,"startTime":"0","endTime":"0","summary":"NEW YORK, Oct.  29, 2025  (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies for cancer and autoimmune disea","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/29/3176342/0/en/IN8bio-Expands-INB-100-Phase-1-Clinical-Trial-with-Addition-of-The-Ohio-State-University-as-New-Site.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","LU1883839398.USD","IE0034235188.USD","INB","IE00BGHQF748.EUR","BK4139","BK4585","LU1894683348.USD","BK4588","BK4539","INAB","LU1894683264.USD","STT","BK4135","LU0061475181.USD","IE00B64PRP62.GBP"],"gpt_icon":0},{"id":"2578455756","title":"IN8bio Inc - Inb-619 Shows Equivalent Efficacy to FDA-Approved Tce Compounds","url":"https://stock-news.laohu8.com/highlight/detail?id=2578455756","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578455756?lang=en_us&edition=fundamental","pubTime":"2025-10-27 20:01","pubTimestamp":1761566464,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251027:nFWN3W81PF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","INAB"],"gpt_icon":0},{"id":"2578764571","title":"IN8bio Presents T cell Engager Data Demonstrating Deep B Cell Depletion for Autoimmune Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=2578764571","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578764571?lang=en_us&edition=fundamental","pubTime":"2025-10-27 20:00","pubTimestamp":1761566400,"startTime":"0","endTime":"0","summary":"INB-619 demonstrated equivalent efficacy to the FDA approved, commercial T Cell Engagers (TCE) compounds, blinatumomab and mosunetuzumab, with minimal adverse cytokine release, highlighting a targeted","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/27/3174505/0/en/IN8bio-Presents-T-cell-Engager-Data-Demonstrating-Deep-B-Cell-Depletion-for-Autoimmune-Indications.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INAB"],"gpt_icon":0},{"id":"2575040513","title":"IN8bio price target adjusted to $4 from $60 at Mizuho","url":"https://stock-news.laohu8.com/highlight/detail?id=2575040513","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575040513?lang=en_us&edition=fundamental","pubTime":"2025-10-13 19:51","pubTimestamp":1760356277,"startTime":"0","endTime":"0","summary":"Mizuho lowered the firm’s price target on IN8bio (INAB) to $4 from $60 and keeps an Outperform rating on the shares. The firm continues to believe ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/in8bio-price-target-adjusted-to-4-from-60-at-mizuho-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/in8bio-price-target-adjusted-to-4-from-60-at-mizuho-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MFG","INAB"],"gpt_icon":0},{"id":"2575477725","title":"IN8bio Inc : Mizuho Adjusts Target Price to $4 From $60 to Reflect Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2575477725","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575477725?lang=en_us&edition=fundamental","pubTime":"2025-10-13 18:42","pubTimestamp":1760352151,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251013:nFWN3VU1VX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INAB","BK4539","BK4139"],"gpt_icon":0},{"id":"2574107053","title":"Mizuho Securities Reaffirms Their Buy Rating on IN8bio (INAB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2574107053","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574107053?lang=en_us&edition=fundamental","pubTime":"2025-10-11 04:35","pubTimestamp":1760128510,"startTime":"0","endTime":"0","summary":"Mizuho Securities analyst Uy Ear maintained a Buy rating on IN8bio today and set a price target of $4.00. The company’s shares closed today at $2.1...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/mizuho-securities-reaffirms-their-buy-rating-on-in8bio-inab-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/mizuho-securities-reaffirms-their-buy-rating-on-in8bio-inab-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INAB","MFG"],"gpt_icon":0},{"id":"2557119519","title":"IN8bio Inc reports results for the quarter ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2557119519","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557119519?lang=en_us&edition=fundamental","pubTime":"2025-08-08 11:17","pubTimestamp":1754623039,"startTime":"0","endTime":"0","summary":"IN8bio Inc reports results for the quarter ended June 30 - Earnings SummaryIN8bio Inc INAB.OQ reported a quarterly adjusted loss of $1.24 per share for the quarter ended June 30, higher than the same ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250808:nL8N3U007M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INAB"],"gpt_icon":0},{"id":"2557596300","title":"IN8bio Q2 EPS $(1.24) Beats $(1.70) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2557596300","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557596300?lang=en_us&edition=fundamental","pubTime":"2025-08-08 04:08","pubTimestamp":1754597325,"startTime":"0","endTime":"0","summary":"IN8bio (NASDAQ:INAB) reported quarterly losses of $(1.24) per share which beat the analyst consensus estimate of $(1.70) by 27.06 percent. This is a 78.25 percent increase over losses of $(5.70) per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/46979437/in8bio-q2-eps-1-24-beats-1-70-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"IN8bio Q2 EPS $(1.24) Beats $(1.70) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INAB"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":27,"code":"91000000","status":"200"}]}}